KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diversified Healthcare Trust (DHC) Income towards Parent Company (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed Income towards Parent Company for 17 consecutive years, with -$48.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company rose 51.16% year-over-year to -$48.3 million, compared with a TTM value of -$331.8 million through Dec 2025, up 23.21%, and an annual FY2025 reading of -$322.6 million, up 13.23% over the prior year.
  • Income towards Parent Company was -$48.3 million for Q4 2025 at Diversified Healthcare Trust, up from -$273.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $366.8 million in Q4 2021 and bottomed at -$273.0 million in Q2 2025.
  • Average Income towards Parent Company over 5 years is -$52.5 million, with a median of -$80.0 million recorded in 2023.
  • The sharpest move saw Income towards Parent Company surged 365.18% in 2021, then crashed 248.88% in 2022.
  • Year by year, Income towards Parent Company stood at $366.8 million in 2021, then plummeted by 117.13% to -$62.8 million in 2022, then fell by 27.28% to -$80.0 million in 2023, then decreased by 23.76% to -$99.0 million in 2024, then soared by 51.16% to -$48.3 million in 2025.
  • Business Quant data shows Income towards Parent Company for DHC at -$48.3 million in Q4 2025, -$273.0 million in Q2 2025, and -$10.5 million in Q1 2025.